Sterile Empty Vial and Injector (30mL PCA vial), Rx only, One/List No. 6021-03, Hospira, Inc., Lake Forest, IL 60045. For use with a compatible Hospira PCA pump set with injector and a compatible Hospira infusion device.
Published September 19, 2012 · Recall initiated: August 2, 2012
Summary
FDA records medical device Class II recall Z-2346-2012, published September 19, 2012 and initiated August 2, 2012. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: unknown; Lot: The letter was issued for all product presently in the field and product that will be released. Specific lot numbers were not indicated in the letter. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Reports of leaking during filling and administration.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira, Inc.
- Distributor
- Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NY, NC, NK, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WY and the countries of Canada, Costa Rica and the Virgin Islands.
- Lot
- The letter was issued for all product presently in the field and product that will be released. Specific lot numbers were not indicated in the letter.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc.,September 30, 2015
- FDA1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.April 23, 2014
- FDAMorphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDCDecember 11, 2013
- FDAKetorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDCSeptember 4, 2013
- FDAVolcano brand Intravascular Ultrasound, Volcano s5/s5i Family Software Version 3.2.1 or 3.2.2, Models/PartSeptember 19, 2012
- FDAPhilips HeartStart MRx monitor/defibrillators Models: M3535A and M3536A, M3536J, M3536M, M3536MC, M3536M1,September 19, 2012
Questions about this recall
Was Sterile Empty Vial and Injector (30mL PCA vial), Rx only, One/List No. 6021-03, Hospira, Inc., Lake Forest, IL 60045. For use with a compatible Hospira PCA pump set with injector and a compatible Hospira infusion device. recalled?
Yes. FDA published recall Z-2346-2012 on September 19, 2012. Reported hazard: Reports of leaking during filling and administration.
What should I do if I have this product?
Voluntary: Firm initiated · Letter